Lebensqualität von Karzinom-Patienten unter Chemo- und Radiotherapie
- 1 January 1986
- journal article
- research article
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 9 (3) , 172-180
- https://doi.org/10.1159/000216002
Abstract
In a prospective study, 156 patients with advanced lung and gastrointestinal carcinomas, receiving palliative chemotherapy or radiotherapy, were examined for changes in their quality of life during therapy. A questionnaire (68 questions), a linear analogue scale, and the Karnofsky performance scale were used three times in the course of therapy. The most important result seen during the evaluation of the questionnaire was the improvement in the physical state in patients with tumor remission, even with increasing side-effects. In patients with progressive disease, a deteriorated psychosocial state and an increased burden due to the toxic side effects were observed. These results were also confirmed in progressive patients by the linear analogue scale. The Karnofsky performance scale showed a high correlation for the judgement of disease-related contents and the activity of the patient. In this study the relationship of treatment results and well-being is shown. It would seem important to include methods for the measurement of quality of life for the evaluation of oncological therapies.Keywords
This publication has 6 references indexed in Scilit:
- Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.Journal of Clinical Oncology, 1984
- Measuring the quality of life of cancer patientsJournal of Chronic Diseases, 1981
- Evaluation of patients with advanced cancer using the karnofsky performance statusCancer, 1980
- Psychological Impairment and Psychological Health in the Psychological Well-Being of the Physically IllPsychosomatic Medicine, 1980
- Scientific problems in clinical scales, as demonstrated in the karnofsky index of performance statusJournal of Chronic Diseases, 1979
- EVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST CANCERThe Lancet, 1976